CDYL and neoplasm: Through MM cohort study and the xenograft tumor model, Chen et al. (Chen et al., 2020b) confirmed that circ-CDYL was elevated in tissue and plasma samples of MM patients; mechanically, circ-CDYL could absorb miR-1180 to upregulate yes-associated protein (YAP) expression, ultimately triggering MM progression.